Evaluation of P21Cip1 and P27Kip1 expression in de novo acute lymphoblastic leukemia patients
Open Access
- 28 July 2018
- journal article
- research article
- Published by Biomedical Research and Therapy in Biomedical Research and Therapy
- Vol. 5 (7), 2518-2527
- https://doi.org/10.15419/bmrat.v5i7.461
Abstract
Background: Acute lymphoblastic leukemia (ALL) arises from an imbalanced proliferation and differentiation of lymphoid progenitors due to special chromosomal and epigenetic abnormalities affecting cell cycle regulation. The cyclin-dependent kinase inhibitor (CDKI) family has crucial functions in G1 progression and G1 to S entry regulation. Among CDKIs, P21 and P27 are able to exert remarkable effects on all CDKs. Hence, we investigated the expression levels of P21 and P27 in ALL patients to determine whether or not their expression had been altered. Materials and Methods: In the present study, we evaluated P21 and P27 expression in bone marrow and peripheral blood samples of 52 newly diagnosed ALL patients (30 males, 22 females) and 13 healthy normal controls (5 males, 8 females) using quantitative real-time PCR. Data were analyzed via SPSS (version 16) software and PResults: Our findings demonstrated lower expression levels of P21 and P27 in ALL patients compared with normal controls (8.33- and 1.69-fold change, respectively). P21 and P27 expression was significantly different between T-cell acute lymphoblastic leukemia (T-ALL) and B-cell acute lymphoblastic leukemia (B-ALL) patients (P= 0.03). Conclusion: Since P21 and P27 are able to influence the activity of both cyclins and CDKs, it is postulated that decreased expression of these genes reduces P21- and P27- mediated suppressive effects on cyclins and CDKs. Therefore, these events facilitate the activation of cyclins and CDKs which may result in cancer progression in ALL patients.Keywords
This publication has 14 references indexed in Scilit:
- Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemiaLeukemia Research, 2011
- Haplotypes of DNA repair and cell cycle control genes, X-ray exposure, and risk of childhood acute lymphoblastic leukemiaCancer Causes & Control, 2011
- Significance of Cell Cycle Regulatory Proteins as Malignant and Prognostic Biomarkers in Ovarian Epithelial TumorsInternational Journal of Gynecological Pathology, 2011
- Expression of the regulatory cell cycle proteins p21, p27, p14, p16, p53, mdm2, and cyclin E in bone marrow biopsies with acute myeloid leukemia. Correlation with patients’ survivalPathology - Research and Practice, 2007
- Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemiaNature, 2007
- Epigenetic inactivation of the CIP/KIP cell-cycle control pathway in acute leukemiasAmerican Journal of Hematology, 2005
- Prognostic impact of p27KIP1 expression in cyclin D1 positive lymphoproliferative disordersLeukemia, 2004
- Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosisGynecologic Oncology, 2003
- p21Cip1 Promotes Cyclin D1 Nuclear Accumulation via Direct Inhibition of Nuclear ExportOnline Journal of Public Health Informatics, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001